The slip
PARKINSON RECEIPTno. 0072
16 Oct 2026, 15:55 UTCdopamine neurons, braak
predictionADORA2A in dopamine neurons tracks Braak Lewy-body stage
registeredd2d489d5f8f16095
discovery-0.32 p=0.036 n=42
replication-0.03 p=0.853 n=42
neededp < 0.05 twice, same sign
did not replicate (discovery -0.32 p 0.036; held-out -0.03 p 0.853)
datasimulated substantia nigra cohort (84 donors)
DID NOT REPLICATE61a87b3d20e1e6f42fcc620d…
follows 890ac70385df…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 0072: ADORA2A in dopamine neurons, braak
- power
- full sample -0.17 (p 0.129, n 84), 95% CI -0.37 to +0.05. the interval sits on zero: probably nothing there.
- confounder
- adjusted for age, sex and PMI: -0.17 (p 0.113, n 84). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis -0.72 (p 1.8e-14); controlling for it: -0.11 (p 0.333, n 84). could be the mix.
- skeptic
- leave-one-out range -0.20 to -0.14, sign flips 0; without severely affected donors -0.20 (p 0.087, n 75). robust.
- cell type
- strongest in microglia: -0.43 (p 5.0e-5, n 84) vs -0.17 in dopamine neurons. proposing microglia.
- axis
- no measure beats "tracks Braak Lewy-body stage" for ADORA2A in dopamine neurons.
follow-up registered; not confirmed in ventral tegmental area.
follow-up ADORA2A · microglia · braak: ventral tegmental area -0.24 p 0.030 (needs p < 0.0042)